News > No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension

No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension

The Siasat | 03/04/2022 10:48 AM | Click to read full article

Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is “no impact on efficacy and safety of the COVID-19 vaccine COVAXIN” after the WHO suspended it from its Covax facility.

“For the millions who have received COVAXIN, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety of the vaccine,” read the statement issued by Bharat Biotech.

-